Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI takes on blood clotting: can ChatGPT guide surgeons on bleeding?

NCT ID NCT07043556

Knowledge-focused Sponsor: Ondokuz Mayıs University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This study evaluates whether artificial intelligence models can accurately interpret ROTEM blood clotting tests and recommend treatments for coagulopathy. Researchers will compare AI decisions to those of a panel of clinical experts using data from adults undergoing elective cardiac or liver transplant surgery. The goal is to see if AI can match expert-level judgment in identifying clotting problems and suggesting appropriate therapies.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Artificial intelligence algorithms (ChatGPT and Gemini) for ROTEM interpretation
What this could lead to
If AI can match expert doctors in reading ROTEM results, it could help standardize bleeding management and speed up treatment decisions during surgery.
What could go wrong
This is a small, early-stage observational study comparing AI to expert opinion, not a trial testing patient outcomes. AI may not perform well enough in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Started

Jul 2025

Expected to finish

Mar 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of adult patients (aged 18 years and older) undergoing elective cardiac surgeries-including coronary artery bypass grafting (CABG), valve surgery, and aortic procedures-and elective liver transplantation procedures. All participants will have complete and analyzable intraoperative ROTEM (Rotational Thromboelastometry) data available. Only patients who are able to provide written informed consent will be enrolled. Emergency cases, pediatric patients, and those with technically invalid ROTEM results will be excluded.

Ages

18 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients undergoing elective cardiac surgery (CABG, valve surgery, aortic procedures) * Adult patients undergoing liver transplantation * Availability of complete ROTEM results (EXTEM, INTEM, FIBTEM, +/- HEPTEM, APTEM) * Informed written consent obtained Exclusion Criteria: * Incomplete or technically invalid ROTEM data * Pediatric patients (\<18 years) * Refusal to participate or lack of informed consent * Emergency and redo surgeries

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coagulopathy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

blood coagulation disease vascular hemostatic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coagulopathy

Contacts and locations

Locations

  • Ondokuz Mayis University

    Samsun, Turkey (Türkiye)

  • İstanbul Aydın Üniversitesi Sağlık Uygulama ve Araştırma Merkezi Medical Park Florya Hastanesi

    Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.